Position in ACHV
as of Dec 31, 2025
· filed Jan 29, 2026
Position Value
$12,297,329
+$4,542,653 QoQ
Shares Held
2,474,312
+0.5% QoQ
Ownership
2.41%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
22 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 12.778380414434395.ToString("F0")%
None 87.2216195855656.ToString("F0")%
Common Shares in ACHV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Dec 31, 2025VANGUARD GROUP INC holds $65,710,461,655 across 449 Biotechnology names. ACHV ranks #210 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
24,105,823 | $10,928,615,912 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,075,153 | $7,004,838,343 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,553,932 | $5,389,721,058 | |
| 4 | INSM |
INSMED Inc
|
21,076,344 | $3,668,126,907 | |
| 5 | INCY |
Incyte Corp
|
19,911,434 | $1,966,652,333 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
16,719,886 | $1,331,738,919 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
16,440,459 | $1,300,604,709 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
16,862,691 | $1,289,827,232 |
All Filings in ACHV
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $12,297,329 | 2,474,312 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $7,754,676 | 2,461,802 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $4,858,721 | 2,149,877 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $4,584,426 | 1,717,014 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $6,159,263 | 1,749,791 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $9,197,438 | 1,940,388 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $7,076,934 | 1,505,731 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,315,406 | 948,441 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $2,495,524 | 605,710 | Shares | Defined | 2024-03-11 | |
| 2023-09-30 | $2,553,997 | 593,953 | Shares | Sole | 2023-12-18 | |
| 2023-06-30 | $2,998,745 | 577,793 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,851,811 | 419,384 | Shares | Sole | 2023-07-14 | |
| 2022-12-31 | $833,583 | 340,238 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,149,432 | 348,313 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,711,025 | 350,620 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,595,790 | 342,905 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,690,128 | 345,775 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,285,284 | 268,857 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,234,959 | 248,882 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,427,088 | 295,949 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $220,384 | 27,208 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $149,036 | 17,806 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||